Analyst consensus rating
CalciMedica Analyst Rating: Strong Buy
CALC is rated Strong Buy by 3 analysts with a $10.00 target. As of 2026-08-24.
Direct answer
CalciMedica's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $10.00.
Forecast evidence checked August 24, 2026.
Get free CalciMedica email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.56
- Average price target
- $10.00
- High price target
- $15.00
- Low price target
- $6.00
- Low target gap
- +978.4%
- Target upside
- +1,697.3%
- High target gap
- +2,595.9%
- Target range width
- 1,617.5%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- August 24, 2026
- Valid through
- August 31, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for CalciMedica?
CalciMedica has a verified Strong Buy consensus. The same dataset has an average price target of $10.00.
How far are CalciMedica's low and high targets from the recorded price?
The low target implies +978.4%, while the high target implies +2,595.9%.
How many analysts are included in CalciMedica's consensus?
The verified consensus includes 3 analysts.
How is CalciMedica's target upside or downside calculated?
The average target of $10.00 is divided by the recorded price of $0.56, then one is subtracted to produce +1,697.3%. This does not guarantee a future return.
When was CalciMedica's analyst forecast verified?
The data was verified on 2026-08-24. The dataset is valid through 2026-08-31.